Here are the best weight loss meal delivery services including low-calorie and low-carb options. We've included both meal ...
Completed randomization in REMAIN-1 Pivotal Cohort; topline 6-Month data expected in early Q4 2026Received favorable FDA feedback on De Novo ...
A child's love of active play and his parents' dream of their own sauna come together in the lower level of a hillside ...
As nanomaterials gain commercial traction, they have the potential to revolutionize medicine, aerospace, and 3D printing, and ...
Adults diagnosed with prediabetes can find a list of local enrollment locations here for participation in the year-long ...
New program delivers family-centered diabetes education, clinical guidance, and device support for pediatric patients ...
Roughly 55 percent of Medicaid enrollees are working full or part time, and a number aren’t eligible for health insurance ...
Wahnefried, Ph.D. and Benjamin Larimer, Ph.D. Researchers at the University of Alabama at Birmingham are advancing cancer ...
Olatec Therapeutics, Inc. ("Olatec"), developing one of the most clinically advanced specific oral NLRP3 inhibitors, dapansutrile, today announced that two patients have been randomized in a 12-month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results